<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01998737</url>
  </required_header>
  <id_info>
    <org_study_id>Bind03</org_study_id>
    <secondary_id>BoneIndex03</secondary_id>
    <nct_id>NCT01998737</nct_id>
  </id_info>
  <brief_title>Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAX</brief_title>
  <official_title>Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAX</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bone Index Finland Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Bone Index Finland Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Osteoporosis is a disease that leads to impaired skeletal strength and increased fracture
      risk. Among 200 million osteoporotic patients (Tarantino, Cannata et al. 2007) most are
      diagnosed only after several fractures. Furthermore, the progressively aging population will
      increase the prevalence of osteoporosis. It is estimated that over 75% of osteoporotic
      patients are not diagnosed and does not receive treatment for their condition.

      In this study we aim to investigate the strength of Density Index (DI) for prediction of
      proximal femur and lumbar spine BMD as well as determining the diagnostic thresholds for DI
      for osteoporosis diagnostics by using the International Society for Clinical Densitometry
      guidelines. In addition we aim to investigate how many additional women would be identified
      for osteoporosis diagnosis/ treatment based on adding FRAX to Bindex versus adding FRAX to
      DXA.

      The investigators will start and organize a multicenter study in 5 osteoporosis clinics in
      Suomen Terveystalo Healthcare Service Company in Finland. A total of 1100 postmenopausal
      women (age 50 -79 years) will be measured with both axial DXA and Bindex. In addition, the
      FRAX questioinnaire will be asked from everybody attending the study.

      Clinical hypotheses:

        1. Cortical bone thickness is decreased in osteoporosis.

        2. Patient age, weight and height are related to BMD status and therefore are needed in BMD
           estimation (Density Index).

        3. Ultrasound is a safe method in osteoporosis screening and diagnostics for osteoporosis.

        4. Fracture risk factors (FRAX) and point-of-care bone density measurement together have
           significantly higher sensitivity and specificity for osteoporosis/treatment decisions
           than one method alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The following procedures will be applied

        -  Signing Informed Consent

        -  Filling in the FRAX questionnaire

        -  DXA measurements of the proximal femur and AP spine

        -  Bindex ultrasound measurement of both the tibia and the radius

      Written informed consent is obtained from all subjects before enrolment to the study. All
      patient data is coded, i.e. made anonymous, to conform to personal data protection. The data
      is processed only for study purposes.

      A total of 1100 postmenopausal women (age 50 -79 years) will participate the study. The
      subjects will be divided into two groups: healthy (100 women) and under osteoporosis
      suspicion (1000 women). The groups will be matched by BMI.

      Written informed consent is obtained from all subjects before enrolment in the study. All
      patient data is coded, i.e. made anonymous, to conform to personal data protection. The data
      is processed only for study purposes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Sensitivity of the Density Index Against Dual Energy X-ray Absorptiometry for Detecting Osteoporosis</measure>
    <time_frame>3 years</time_frame>
    <description>The thresholds for the Density Index (DI) in osteoporosis diagnostics in comparison to dual energy x-ray absorptiometry (DXA) are evaluated in independent population.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity of the Density Index Against Dual Energy X-ray Absorptiometry for Detecting Osteoporosis</measure>
    <time_frame>3 years</time_frame>
    <description>The thresholds for the Density Index (DI) in osteoporosis diagnostics in comparison to dual energy x-ray absorptiometry (DXA) are evaluated in independent population.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants That Would Require Additional DXA Examination to Confirm Diagnosis</measure>
    <time_frame>3 years</time_frame>
    <description>The previously determined thresholds have been applied. The results show amount of subject whose DI value is between the thresholds. These subjects would need DXA measurement to verify diagnosis.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1011</enrollment>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>Women under osteoporosis suspicion</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy women</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 1100 postmenopausal women (age 50 -79 years) will participate the study. The
        subjects will be divided into two groups: healthy (100 women) and under osteoporosis
        suspicion (1000 women). The groups will be matched by BMI.

        Women for the under osteoporosis suspicion group will be invited from those who have got a
        referral for DXA examination from their doctor.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Osteoporosis suspicion

        Inclusion Criteria:

          -  Age: 50 - 59 years (n = 500) and 60-79 years (n = 500).

          -  Post-menopausal status.

          -  At least one of the clinical risk factors for fracture:

               -  Low body mass index (&lt; 19kg/m2)

               -  Previous fragility fracture

               -  Parental history of hip fracture

               -  Glucocorticoid treatment (≥ 5mg prednisolone daily or equivalent for 3 months or
                  more)

               -  Current smoking

          -  Alcohol intake 3 or more units daily

          -  Causes of secondary osteoporosis:

               -  Untreated hypogonadism

               -  Inflammatory bowel disease

               -  Prolonged immobility

               -  Organ transplantation

               -  Type 1 and type 2 diabetes

               -  Thyroid disorders

               -  Chronic obstructive pulmonary disease

          -  A Physician has referred the woman to axial DXA investigation.

        Exclusion Criteria:

          -  Treatment: osteoporosis medication.

          -  Obesity: body mass index BMI &gt; 30kg/m2

          -  a refusal to participate in the study

        Healthy

        Inclusion Criteria:

          -  Age: 50 - 59 years (n = 50) and 60-79 years (n = 50).

          -  Post-menopausal status.

          -  No diseases or treatments which may affect to bone health.

        Exclusion Criteria:

          -  Treatment: osteoporosis medication.

          -  a refusal to participate in the study

          -  Obesity: body mass index BMI &gt; 30kg/m2
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heikki Kröger, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kuopio University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janne P Karjalainen, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Bone Index Finland Ltd</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ossi Riekkinen, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Bone Index Finland Ltd</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Terveystalo Kamppi</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Terveystalo Jyväskylä</name>
      <address>
        <city>Jyväskylä</city>
        <zip>40100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Terveystalo Kouvola</name>
      <address>
        <city>Kouvola</city>
        <zip>45100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Terveystalo Lahti</name>
      <address>
        <city>Lahti</city>
        <zip>15110</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Terveystalo Mikkeli Marski</name>
      <address>
        <city>Mikkeli</city>
        <zip>50100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 25, 2013</study_first_submitted>
  <study_first_submitted_qc>November 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2013</study_first_posted>
  <results_first_submitted>November 4, 2016</results_first_submitted>
  <results_first_submitted_qc>May 2, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 11, 2017</results_first_posted>
  <last_update_submitted>August 18, 2017</last_update_submitted>
  <last_update_submitted_qc>August 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoporosis, diagnostics, ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Women Under Osteoporosis Suspicion</title>
          <description>Subjects with at least one risk factor for osteoporotic fracture.</description>
        </group>
        <group group_id="P2">
          <title>Healthy Women</title>
          <description>In healthy group females without risk factors for fracture or diseases affecting bone health were recruited.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="911"/>
                <participants group_id="P2" count="100"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="888"/>
                <participants group_id="P2" count="100"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Corrupted database</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Women Under Osteoporosis Suspicion</title>
        </group>
        <group group_id="B2">
          <title>Healthy Women</title>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="888"/>
            <count group_id="B2" value="100"/>
            <count group_id="B3" value="988"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="453"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="527"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="435"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="461"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.3" spread="7"/>
                    <measurement group_id="B2" value="61.6" spread="6.6"/>
                    <measurement group_id="B3" value="64.9" spread="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="888"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="988"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="888"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="988"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Finland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="888"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="988"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.2" spread="9.9"/>
                    <measurement group_id="B2" value="65.5" spread="9.2"/>
                    <measurement group_id="B3" value="64.4" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="161.5" spread="6.1"/>
                    <measurement group_id="B2" value="162.3" spread="6.1"/>
                    <measurement group_id="B3" value="161.5" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sensitivity of the Density Index Against Dual Energy X-ray Absorptiometry for Detecting Osteoporosis</title>
        <description>The thresholds for the Density Index (DI) in osteoporosis diagnostics in comparison to dual energy x-ray absorptiometry (DXA) are evaluated in independent population.</description>
        <time_frame>3 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Women Under Osteoporosis Suspicion</title>
            <description>As defined in the protocol</description>
          </group>
          <group group_id="O2">
            <title>Healthy Women</title>
            <description>As defined in the protocol</description>
          </group>
        </group_list>
        <measure>
          <title>Sensitivity of the Density Index Against Dual Energy X-ray Absorptiometry for Detecting Osteoporosis</title>
          <description>The thresholds for the Density Index (DI) in osteoporosis diagnostics in comparison to dual energy x-ray absorptiometry (DXA) are evaluated in independent population.</description>
          <units>percentage of true positives</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="888"/>
                <count group_id="O2" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.7"/>
                    <measurement group_id="O2" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Specificity of the Density Index Against Dual Energy X-ray Absorptiometry for Detecting Osteoporosis</title>
        <description>The thresholds for the Density Index (DI) in osteoporosis diagnostics in comparison to dual energy x-ray absorptiometry (DXA) are evaluated in independent population.</description>
        <time_frame>3 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Women Under Osteoporosis Suspicion</title>
            <description>As defined in the protocol</description>
          </group>
          <group group_id="O2">
            <title>Healthy Women</title>
            <description>As defined in the protocol</description>
          </group>
        </group_list>
        <measure>
          <title>Specificity of the Density Index Against Dual Energy X-ray Absorptiometry for Detecting Osteoporosis</title>
          <description>The thresholds for the Density Index (DI) in osteoporosis diagnostics in comparison to dual energy x-ray absorptiometry (DXA) are evaluated in independent population.</description>
          <units>percentage of true negatives</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="888"/>
                <count group_id="O2" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.6"/>
                    <measurement group_id="O2" value="93.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants That Would Require Additional DXA Examination to Confirm Diagnosis</title>
        <description>The previously determined thresholds have been applied. The results show amount of subject whose DI value is between the thresholds. These subjects would need DXA measurement to verify diagnosis.</description>
        <time_frame>3 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Women Under Osteoporosis Suspicion</title>
            <description>As defined in the protocol</description>
          </group>
          <group group_id="O2">
            <title>Healthy Women</title>
            <description>As defined in the protocol</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants That Would Require Additional DXA Examination to Confirm Diagnosis</title>
          <description>The previously determined thresholds have been applied. The results show amount of subject whose DI value is between the thresholds. These subjects would need DXA measurement to verify diagnosis.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="888"/>
                <count group_id="O2" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="288"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Study duration 3 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Women Under Osteoporosis Suspicion</title>
        </group>
        <group group_id="E2">
          <title>Healthy Women</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="888"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="888"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>CTO</name_or_title>
      <organization>Bone Index Finland Ltd.</organization>
      <phone>+358 45 896 2650</phone>
      <email>janne.karjalainen@boneindex.fi</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

